[1]
Hemalatha S and Monisha J 2020. Formulation and evaluation of anti-diabetic activity of repaglinide nanosuspension. International Journal of Pharmaceutical Research and Life Sciences. 8, 2 (Jul. 2020), 17-21. DOI:https://doi.org/10.26452/ijprls.v8i2.1208.